|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/136 | (2013.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3507384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17771623.0 |
| Date of filing the European patent application | 2017-08-31 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/049747 |
| Date | 2017-08-31 |
| (87) | Number | WO 2018/045240 |
| Date | 2018-03-08 |
| (30) | Number | Date | Country code |
| 201662382734 P | 2016-09-01 | US | |
| 201662414601 P | 2016-10-28 | US |
| (72) |
LUO, Wen , US
SUN, Hong , US
|
| (73) |
Denovo Biopharma LLC ,
6331 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN |
| METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN |